New York State Common Retirement Fund grew its holdings in Insulet Co. (NASDAQ:PODD – Get Rating) by 6.0% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 95,353 shares of the medical instruments supplier’s stock after acquiring an additional 5,424 shares during the period. […]
Riverstone Advisors LLC cut its position in Insulet Co. (NASDAQ:PODD – Get Rating) by 6.7% during the fourth quarter, Holdings Channel.com reports. The institutional investor owned 15,087 shares of the medical instruments supplier’s stock after selling 1,086 shares during the quarter. Insulet accounts for 3.1% of Riverstone Advisors LLC’s investment portfolio, making the stock its […]
Shares of Insulet Co. (NASDAQ:PODD – Get Rating) have been assigned a consensus recommendation of “Moderate Buy” from the fourteen ratings firms that are covering the firm, Marketbeat reports. Five investment analysts have rated the stock with a hold recommendation and five have assigned a buy recommendation to the company. The average twelve-month price objective […]
Insulet Co. (NASDAQ:PODD – Get Rating) has been assigned a consensus rating of “Moderate Buy” from the fourteen research firms that are currently covering the company, MarketBeat Ratings reports. Five investment analysts have rated the stock with a hold rating and five have issued a buy rating on the company. The average 12 month target […]
Insulet Co. (NASDAQ:PODD – Get Rating) CFO Wayde D. Mcmillan sold 1,255 shares of the stock in a transaction dated Monday, April 3rd. The stock was sold at an average price of $318.31, for a total transaction of $399,479.05. Following the completion of the transaction, the chief financial officer now directly owns 22,865 shares of […]